RxDoctor Payments Data

Lane Heder, PA

Physician Assistant · Layton, UTNPI 1083641286

Payments from drug & device makers

$4,590in general payments, 2019–2025

Across 289 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$346
  • Lilly USA, LLC$271
  • Abbott$237
  • GSK$158
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$140
  • plus $2K from 42 others

What the payments were for

  • Food & beverage$4,578100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,590 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$56,975
Medicare patients
147
Services billed
2,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide35$35,991
TrulicityDulaglutide21$35,188
FarxigaDapagliflozin Propanediol33$30,243
LinzessLinaclotide27$25,550
Tresiba Flextouch U-200Insulin Degludec13$24,238
XareltoRivaroxaban21$23,104
JanuviaSitagliptin Phosphate23$19,387
EliquisApixaban20$17,121
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$14,769
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,933
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$5,612
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine97$2,707
Omeprazole97$2,390
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen55$2,275
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$271$71,85485 claims
AstraZenecaFarxiga, Breztri Aerosphere$102$45,01257 claims
AbbVieLinzess$1,143$25,55027 claims
Johnson & JohnsonXarelto$93$23,10421 claims
MerckJanuvia$72$19,38723 claims
PfizerEliquis$346$17,12120 claims
GSKTrelegy Ellipta$158$11,93314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →